Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.
about
Moving towards effective therapeutic strategies for Neuronal Ceroid LipofuscinosisDrug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systemsBiophysically inspired model for functionalized nanocarrier adhesion to cell surface: roles of protein expression and mechanical factorsChitosan-Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM-1-Targeting Nanocarriers, Enabling GI Targeting In Vivo.Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors.The Future of Nanoparticle-Directed Venous Therapy.Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.How Carrier Size and Valency Modulate Receptor-Mediated Signaling: Understanding the Link between Binding and Endocytosis of ICAM-1-Targeted Carriers.Evaluation of Receptor-Ligand Mechanisms of Dual-Targeted Particles to an Inflamed Endothelium.ATB0,+ transporter-mediated targeting delivery to human lung cancer cells via aspartate-modified docetaxel-loading stealth liposomes.Doxorubicin and cisplatin loaded nanostructured lipid carriers for breast cancer combination chemotherapy.The Multifaceted Uses and Therapeutic Advantages of Nanoparticles for Atherosclerosis Research.
P2860
Q26753109-66BF7CC6-BEAE-49B8-A463-C3019F9D0C4AQ26798467-10D454EF-F308-4296-A1C4-BDC8A4973E23Q28596891-CF3FE754-E203-4046-A2D6-67C0D53F0BB4Q37051502-A3705892-288E-4388-B3F7-140ADF0742D6Q38364218-E7049E3F-A5A8-473E-8460-A403167A6478Q38749932-28934983-AFF8-4371-AA50-4A13EAF59CC0Q38838043-D22854BC-EA6D-43FA-86F1-A92A06FA9599Q47276739-94166912-D996-455F-8795-018E2133C641Q51055092-9DAE0F26-2974-434E-9AA3-12B41E00EB04Q51073220-6F22FAFB-1ACD-48E6-A095-D701BA75892AQ53785838-72A236AA-F55D-4C34-A21B-6AD900F527D9Q54402965-819CF012-4A53-44A3-AAEB-68EFA3BDE27A
P2860
Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Combination-targeting to multi ...... and their therapeutic cargoes.
@ast
Combination-targeting to multi ...... and their therapeutic cargoes.
@en
Combination-targeting to multi ...... and their therapeutic cargoes.
@nl
type
label
Combination-targeting to multi ...... and their therapeutic cargoes.
@ast
Combination-targeting to multi ...... and their therapeutic cargoes.
@en
Combination-targeting to multi ...... and their therapeutic cargoes.
@nl
prefLabel
Combination-targeting to multi ...... and their therapeutic cargoes.
@ast
Combination-targeting to multi ...... and their therapeutic cargoes.
@en
Combination-targeting to multi ...... and their therapeutic cargoes.
@nl
P2093
P2860
P1476
Combination-targeting to multi ...... and their therapeutic cargoes.
@en
P2093
Iason Papademetriou
Silvia Muro
Zois Tsinas
P2860
P356
10.1016/J.JCONREL.2014.06.008
P407
P577
2014-06-14T00:00:00Z